ImmuneXcite
Year
2011
Area
Healthcare and Medical
ImmuneXcite developed a disease and cancer therapy by enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets.
Compound to enhance immune stimulation
This company was a spinout of the 2007 project, Compound to enhance immune stimulation.